» Articles » PMID: 27718551

Paired Design of DCas9 As a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains

Abstract

We developed an in vitro DNA detection system using a pair of dCas9 proteins linked to split halves of luciferase. Luminescence was induced upon colocalization of the reporter pair to a ∼44 bp target sequence defined by sgRNAs. We used the system to detect Mycobacterium tuberculosis DNA with high specificity and sensitivity. The reprogrammability of dCas9 was further leveraged in an array design that accesses sequence information across the entire genome.

Citing Articles

CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.

Rasool H, Chen Q, Gong X, Zhou J FASEB J. 2024; 38(24):e70252.

PMID: 39726403 PMC: 11671863. DOI: 10.1096/fj.202401569R.


Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects.

Sahel D, Giriprasad G, Jatyan R, Guha S, Korde A, Mittal A RSC Adv. 2024; 14(44):32411-32435.

PMID: 39403159 PMC: 11472282. DOI: 10.1039/d4ra04838e.


CRISPR for companion diagnostics in low-resource settings.

Qian X, Xu Q, Lyon C, Hu T Lab Chip. 2024; 24(20):4717-4740.

PMID: 39268697 PMC: 11393808. DOI: 10.1039/d4lc00340c.


Exploring the Thermostability of CRISPR-Cas12b using Molecular Dynamics Simulations.

Jia Y, Horvath K, Rananaware S, Jain P, Sampath J ArXiv. 2024; .

PMID: 39253640 PMC: 11383325.


Mycobacterium tuberculosis Detection Using CRISPR Technology: An Updated Systematic Review and Meta-analysis.

Abavisani M, Karbas Foroushan S, Khayami R, Sahebkar A Mol Diagn Ther. 2024; 28(6):777-790.

PMID: 39212838 DOI: 10.1007/s40291-024-00741-x.